ConductScience.org, home

Paper41596012

Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models.

Muir KC and 7 others. Bioengineering (Basel), 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models. Papers, record 41596012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models.
PubMed
Journal
Bioengineering (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-01-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muir KCKelsey Chttps://orcid.org/0000-0001-8768-5468
2Zheng CClarkhttps://orcid.org/0000-0002-2299-841X
3Yalamanchili KKeertana
4Reddy RRiyahttps://orcid.org/0000-0002-2033-6279
5Joseph AAlexander
6Hamze JJad
7Harris DDDwight D
8Sellke FWFrank Whttps://orcid.org/0000-0002-8886-801X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
1R01HL046716-00NIH HHSUnited StatesR01HL046716PubMedNIH RePORTER
1R01HL128831-00NIH HHSUnited StatesR01HL128831PubMedNIH RePORTER
1T32HL160517-03NIH HHSUnited StatesT32HL160517PubMedNIH RePORTER

Download CSV of grants

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124805242c-kit+ cells minimally contribute cardiomyocytes to the heart.Nature2014https://conductscience.org/library/papers/24805242PubMed
229570208Sheep can be used as animal model of regional myocardial remodeling and controllable work.Cardiol J2019https://conductscience.org/library/papers/29570208PubMed
320395342Challenges in the translation of cardiovascular cell therapy.J Nucl Med2010https://conductscience.org/library/papers/20395342PubMed
438885303Advanced Cardiac Patches for the Treatment of Myocardial Infarction.Circulation2024https://conductscience.org/library/papers/38885303PubMed
534409022Comparison of Swine and Human Computational Hemodynamics Models for the Study of Coronary Atherosclerosis.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/34409022PubMed
634793116Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.ACS Appl Mater Interfaces2021https://conductscience.org/library/papers/34793116PubMed
737554270Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue.Theranostics2023https://conductscience.org/library/papers/37554270PubMed
815812508Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.Nat Med2005https://conductscience.org/library/papers/15812508PubMed
919081827Zebrafish Heart Regeneration as a Model for Cardiac Tissue Repair.Drug Discov Today Dis Models2007https://conductscience.org/library/papers/19081827PubMed
1037192972Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.iScience2023https://conductscience.org/library/papers/37192972PubMed
1130819021Native Coronary Collateral Microcirculation Reserve in Rat Hearts.J Am Heart Assoc2019https://conductscience.org/library/papers/30819021PubMed
1237888397Engineered Vesicles and Hydrogel Technologies for Myocardial Regeneration.Gels2023https://conductscience.org/library/papers/37888397PubMed
1336768399Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium.Int J Mol Sci2023https://conductscience.org/library/papers/36768399PubMed
1424140081Small and large animal models in cardiac contraction research: advantages and disadvantages.Pharmacol Ther2014https://conductscience.org/library/papers/24140081PubMed
1537065655316Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches.Int J Bioprint2023https://conductscience.org/library/papers/37065655PubMed
1640159511Preclinical extracellular matrix-based treatment strategies for myocardial infarction: a systematic review and meta-analysis.Commun Med (Lond)2025https://conductscience.org/library/papers/40159511PubMed
1738444042Cardiac progenitor cell therapy: mechanisms of action.Cell Biosci2024https://conductscience.org/library/papers/38444042PubMed
1828249798Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis.Biochim Biophys Acta Mol Basis Dis2017https://conductscience.org/library/papers/28249798PubMed
1931219741The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.Circ Res2019https://conductscience.org/library/papers/31219741PubMed
2039897258Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease.Cureus2025https://conductscience.org/library/papers/39897258PubMed

See all 194 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42395877Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review.Front Cardiovasc Med2026https://conductscience.org/library/papers/42395877

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41596012

GET https://conductscience.org/api/papers/v1/41596012/references?page=2